SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8%- salicylic acid 2% /sodium sulfacetamide monohydrate 8% suspension 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

SALICYLIC ACID 2% / SODIUM SULFACETAMIDE MONOHYDRATE 8%

Directions for use

wd

Sincerus Florida, LLC. Adverse reactions

ss

Active, inactive

sad

NDC 72934- 8170-7 SALICYLIC ACID USP 2% / SODIUM SULFACETAMIDE MONOHYDRATE USP 8% . Suspension 240gm

cc

SALICYLIC ACID 2% /SODIUM SULFACETAMIDE MONOHYDRATE 8% 
salicylic acid 2% /sodium sulfacetamide monohydrate 8% suspension
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-8170
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SULFACETAMIDE SODIUM (UNII: 4NRT660KJQ) (SULFACETAMIDE - UNII:4965G3J0F5) SULFACETAMIDE SODIUM8 g  in 100 g
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 g
Product Characteristics
ColoryellowScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-8170-7240 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product05/17/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/17/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-8170)

Revised: 5/2019
Document Id: 8904a507-bc77-5430-e053-2995a90a2ac8
Set id: 8904a507-bc76-5430-e053-2995a90a2ac8
Version: 1
Effective Time: 20190516
 
Sincerus Florida, LLC